Biggest News Aggregation in the World
📰 Webcast Information News

Page 32 - Webcast Information News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Webcast Information. Real-time updates on events, politics, business and more.

Merus N.V.: Merus Presents Clinical Data on Zenocutuzumab (Zeno) in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Oral Abstract)

34% overall response rate in 79 evaluable patients with measurable disease9.1 months median duration of responseTumor reduction in 70% of patientsZeno observed to be very well-toleratedPotential new standard
United Kingdom Andrew Joe Alison Schram Exchange Commission Early Access Program Company Conference Call

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Merus N.V.: Merus Announces Publication of Abstract of Zenocutuzumab in NRG1-fusion (NRG1+) Cancer at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

- Robust 34% overall response rate and 9.1 months median duration of response across multiple NRG1+ tumor types - Zenocutuzumab observed to be well-tolerated - Oral presentation with additional
United Kingdom Andrew Joe Alison Schram Exchange Commission Company Conference Call Memorial Sloan Kettering Cancer Center

Skyline Champion Announces Fourth Quarter and Full Year Fiscal 2022 Results

23.05.2022 - Skyline Champion Corporation (NYSE: SKY) (“Skyline Champion”) today announced financial results for its fourth quarter and full year ended April 2, 2022 (“fiscal 2022”). Last year’s results included an extra week during the fourth quarter compared ...
United States Mark Yost Exchange Commission Skyline Champion Corporation Skyline Champion Chief Executive

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science